Literature DB >> 22002595

Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights.

Kimberly Ng1, Ryan Kim, Santosh Kesari, Bob Carter, Clark C Chen.   

Abstract

With advances in genomic profiling and sequencing technology, we are beginning to understand the landscape of the genetic events that accumulated during the neoplastic process. The insights gleamed from these genomic profiling studies with regards to glioblastoma etiology has been particularly satisfying because it cemented the clinical pertinence of major concepts in cancer biology-concepts developed over the past three decades. This article will review how the glioblastoma genomic data set serves as an illustrative platform for the concepts put forward by Hanahan and Weinberg on the cancer phenotype. The picture emerging suggests that most glioblastomas evolve along a multitude of pathways rather than a single defined pathway. In this context, the article will further provide a discussion of the subtypes of glioblastoma as they relate to key principles of developmental neurobiology.

Entities:  

Mesh:

Year:  2011        PMID: 22002595     DOI: 10.1007/s11060-011-0714-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  77 in total

Review 1.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  Reactive astrocytes: cellular and molecular cues to biological function.

Authors:  J L Ridet; S K Malhotra; A Privat; F H Gage
Journal:  Trends Neurosci       Date:  1997-12       Impact factor: 13.837

Review 3.  Involvement of RB gene family in tumor angiogenesis.

Authors:  C Gabellini; D Del Bufalo; G Zupi
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

4.  A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs.

Authors:  Tae-Min Kim; Wei Huang; Richard Park; Peter J Park; Mark D Johnson
Journal:  Cancer Res       Date:  2011-03-08       Impact factor: 12.701

5.  Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.

Authors:  Marta M Alonso; Juan Fueyo; Jerry W Shay; Kenneth D Aldape; Hong Jiang; Ok-Hee Lee; David G Johnson; Jing Xu; Yasuko Kondo; Takao Kanzawa; Satoru Kyo; B Nebiyou Bekele; Xian Zhou; Janice Nigro; J Matthew McDonald; W K Alfred Yung; Candelaria Gomez-Manzano
Journal:  J Natl Cancer Inst       Date:  2005-11-02       Impact factor: 13.506

6.  Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation.

Authors:  Yuan Zhu; Takayuki Harada; Li Liu; Mark E Lush; Frantz Guignard; Chikako Harada; Dennis K Burns; M Livia Bajenaru; David H Gutmann; Luis F Parada
Journal:  Development       Date:  2005-12       Impact factor: 6.868

7.  Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha.

Authors:  Shimin Zhao; Yan Lin; Wei Xu; Wenqing Jiang; Zhengyu Zha; Pu Wang; Wei Yu; Zhiqiang Li; Lingling Gong; Yingjie Peng; Jianping Ding; Qunying Lei; Kun-Liang Guan; Yue Xiong
Journal:  Science       Date:  2009-04-10       Impact factor: 47.728

8.  The retinoblastoma gene is involved in malignant progression of astrocytomas.

Authors:  J W Henson; B L Schnitker; K M Correa; A von Deimling; F Fassbender; H J Xu; W F Benedict; D W Yandell; D N Louis
Journal:  Ann Neurol       Date:  1994-11       Impact factor: 10.422

Review 9.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

10.  A prospective study of neurofibromatosis type 1 cancer incidence in the UK.

Authors:  L Walker; D Thompson; D Easton; B Ponder; M Ponder; I Frayling; D Baralle
Journal:  Br J Cancer       Date:  2006-06-20       Impact factor: 7.640

View more
  25 in total

1.  Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression.

Authors:  David Kozono; Jie Li; Masayuki Nitta; Oltea Sampetrean; David Gonda; Deepa S Kushwaha; Dmitry Merzon; Valya Ramakrishnan; Shan Zhu; Kaya Zhu; Hiroko Matsui; Olivier Harismendy; Wei Hua; Ying Mao; Chang-Hyuk Kwon; Hideyuki Saya; Ichiro Nakano; Donald P Pizzo; Scott R VandenBerg; Clark C Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-09       Impact factor: 11.205

Review 2.  NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age.

Authors:  G Kenneth Gray; Braden C McFarland; Susan E Nozell; Etty N Benveniste
Journal:  Expert Rev Neurother       Date:  2014-09-29       Impact factor: 4.618

3.  Targeting the cancer cell state.

Authors:  Kyungjae Myung
Journal:  Cell Cycle       Date:  2015-06-17       Impact factor: 4.534

4.  A Glioblastoma Genomics Primer for Clinicians.

Authors:  John D Patterson; Thidathip Wongsurawat; Analiz Rodriguez
Journal:  Med Res Arch       Date:  2020-02-21

Review 5.  Survival trends of oligodendroglial tumor patients and associated clinical practice patterns: a SEER-based analysis.

Authors:  Michael G Brandel; Ali A Alattar; Brian R Hirshman; Xuezhi Dong; Kate T Carroll; Mir Amaan Ali; Bob S Carter; Clark C Chen
Journal:  J Neurooncol       Date:  2017-04-24       Impact factor: 4.130

6.  MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.

Authors:  Li Hong; Liu Ya-Wei; Wang Hai; Zhou Qiang; Li Jun-Jie; Annie Huang; Qi Song-Tao; Lu Yun-Tao
Journal:  J Neurooncol       Date:  2016-03-12       Impact factor: 4.130

7.  Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid.

Authors:  Johnny C Akers; Valya Ramakrishnan; Isaac Yang; Wei Hua; Ying Mao; Bob S Carter; Clark C Chen
Journal:  Cancer Biomark       Date:  2016-03-25       Impact factor: 4.388

8.  MicroRNA-96 Regulates Apoptosis by Targeting PDCD4 in Human Glioma Cells.

Authors:  Qing-Qing Ma; Jian-Ting Huang; Yun-Gang Xiong; Xiao-Yan Yang; Ran Han; Wang-Wen Zhu
Journal:  Technol Cancer Res Treat       Date:  2016-07-07

9.  Survival trends of grade I, II, and III astrocytoma patients and associated clinical practice patterns between 1999 and 2010: A SEER-based analysis.

Authors:  Xuezhi Dong; Abraham Noorbakhsh; Brian R Hirshman; Tianzan Zhou; Jessica A Tang; David C Chang; Bob S Carter; Clark C Chen
Journal:  Neurooncol Pract       Date:  2015-07-01

10.  Differential Effects of Cold Atmospheric Plasma in the Treatment of Malignant Glioma.

Authors:  Alan Siu; Olga Volotskova; Xiaoqian Cheng; Siri S Khalsa; Ka Bian; Ferid Murad; Michael Keidar; Jonathan H Sherman
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.